| Drug Name |
Dexchlorpheniramine maleate |
| Drug ID |
BADD_D00627 |
| Description |
Dexchlorpheniramine is the S-enantiomer of chlorpheniramine which is a 1st generation anti-histamine. Dexchlorpheniramine has more pharmacological activity than the R and so is more potent than the racemic mixture. |
| Indications and Usage |
Dexchlorpheniramine can be used in the treatment of perennial and seasonal allergic rhinitis, vasomotor rhiniti, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, and dermographism. |
| Marketing Status |
approved |
| ATC Code |
R06AB02 |
| DrugBank ID |
DB09555
|
| KEGG ID |
D00668
|
| MeSH ID |
C018904
|
| PubChem ID |
5281070
|
| TTD Drug ID |
D05ZGQ
|
| NDC Product Code |
63943-4683; 15370-150; 12294-0010; 64543-600; 49452-2467; 61281-3400 |
| UNII |
B10YD955QW
|
| Synonyms |
dexchlorpheniramine | dexclorfeniramine | dexchlorpheniramine, (+-)-isomer | dexchlorpheniramine, (R)-isomer | dexchlorpheniramine, monohydrochloride, (S)-isomer | Dexclor | Polaramine | Polaramin | dexchlorpheniramine monohydrochloride | Polaronil | dexchlorpheniramine maleate | dextrochlorpheniramine maleate | dexchlorpheniramine maleate (1:1), (+-)-isomer | dexchlorpheniramine maleate (1:1), (R)-isomer | dexchlorpheniramine maleate (1:1), (S)-isomer | dexchlorpheniramine sodium maleate (1:1) | Polargen TD |
